fbpx
MAKING <span style="color: #f06b30;">GENOMICS</span> WORK <br> AT THE<span style="color: #047491;"> POINT OF CARE</span>

MAKING GENOMICS WORK
AT THE POINT OF CARE

What is CDSS?

Clinical Decision Support System (CDSS)

The Clinical Decision Support System (CDSS) at Precision Diagnostics is a proprietary digital interface designed to bridge the gap between complex genomic data and real-time clinical decision-making. Integrated into our Clinical Accredited Reports, Doctor PortalElectronic Health Record (PreciseEHR) systems, and Electronic Medical Record (EMR), it empowers healthcare professionals to make accurate, timely, and personalised therapeutic choices.

The reason behind

Why PRECISE-CDSS Matters

Clinical decisions based on traditional protocols do not account for genetic variability, which may lead to adverse drug reactions, ineffective treatments, and unnecessary hospital readmissions.

A 2022 study by Keogh, Fragala, and colleagues revealed that “DNA testing, a clinical decision support system, and pharmacists were used together to identify medication safety and effectiveness issues and recommend appropriate changes.” This highlights the essential role of PRECISE-CDSS in interpreting pharmacogenomics data and supporting safer, evidence-based prescribing.

key features

Core Capabilities

Guideline Integration and Knowledge Base

Integrates trusted pharmacogenomic guidelines such as CPIC, FDA, DPWG, IWPC or drug label recommendations, enabling evidence-based alerts and recommendations.

Genotype-to-Drug Interpretation Module

Automatically translates raw genetic test results (e.g., CYP2C19 *2/*3) into clinically meaningful phenotypes (e.g., poor metabolizer), ensuring accurate interpretation for decision-making.

Clinical Actionable for Alternative Drug Recommendations

Suggests alternative medications with safer or more effective pharmacogenomic profiles

Clinical Actionable for Dose Optimization

Provides evidence-based dosage adjustments, reducing the risk of over- or under-dosing.

Clinician-Friendly Interface

Includes brief clinical evidence explanations and guideline references within alerts to help clinicians understand the pharmacogenomic rationale behind each recommendation.

Patient-Centric View

Delivers easy-to-understand summaries for patients that increase confidence and adherence to genetic-guided treatments provided by healthcare providers.

Preemptive Decision Support

Stores and reuses genetic information for future prescriptions, providing proactive alerts even before an adverse event or new order occurs.

Data Security and Privacy Framework

Implements robust access control and encryption to protect sensitive genetic and health data, complying with regulations like PDPA.

By embedding the PRECISE-CDSS into every clinical interaction, we turn data into informed decisions and genetics into genuine health outcomes. We do this reliably, securely, and intelligently. 

PRECISE PANEL PARTNER

Become a Panel Partner Today!

Empower your patients with personalized, precision-based healthcare. Join us in offering cutting-edge PRECISE services.

Precise PGx and NGx report

Source: Keogh M, Fragala MS, Peter AP, Lorenz RA, Goldberg SE, Shaman JA. Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee Population. J Occup Environ Med. 2022 Dec 1;64(12):e818-e822. doi: 10.1097/JOM.0000000000002705. Epub 2022 Sep 22. PMID: 36155954; PMCID: PMC9722373.